Although a case of Severe acute respiratory syndrome (SARS-CoV) has not been documented since 2004, NIAID continues to support more than a dozen research projects on this coronavirus throughout the United States, because the knowledge can be applied to other studies. Those studies include developing SARS treatments, a vaccine, and a better understanding of how the virus interacts with the immune system.
When Middle East Respiratory Syndrome (MERS-CoV) emerged in 2012, NIAID lab scientists and NIAID-funded scientists mobilized quickly to research the virus. Key areas of investigation include basic research on where MERS-CoV comes from and how it causes disease, the development of animal models to study the virus, and the development of treatments and vaccines.
Through the information offered here, researchers can learn about the science being conducted at NIAID and by NIAID-funded researchers. Researchers seeking funding can access opportunities to further their own research, while NIAID and NIH grantees can find out about available resources outside of specific funding opportunities. Recent publications, active networks, and ways to connect with other researchers are also available.